The Global Liver Fibrosis Treatment Industry is on the cusp of a remarkable surge, projected to reach a staggering US$46.65 billion by the year 2033. This translates to an unparalleled Compound Annual Growth Rate (CAGR) of 11% anticipated between 2023 and 2033. Fueled by this exceptional growth, the market, valued at US$16.43 billion in 2022, …